Notably, shared features are observed between anti‐MDA5+ RP‐ILD and COVID‐19, such as proinflammatory Mo‐AM infiltration,58 decreased HLA‐DR expression on CD14+ monocytes,59, 60 and distinct peripheral‐lung immune responses.61 Here, IFIH1 is linked to COVID-19.